Amer Bio Medica Analysis

Amer Pink Sheet Analysis Notes

About 31.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Amer Bio Medica had not issued any dividends in recent years. American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York. Amer Bio operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 32 people.The quote for Amer Bio Medica is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Amer Bio Medica please contact Melissa Waterhouse at 518 758 8158 or go to https://www.abmc.com.

Amer Bio Medica Investment Alerts

Amer Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 480.99 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amer Bio's market, we take the total number of its shares issued and multiply it by Amer Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Amer Profitablity

The company has Profit Margin (PM) of (1.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.93) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.93.

Amer Bio Outstanding Bonds

Amer Bio Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Amer Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amer shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Amer Bio. By using and applying Amer Pink Sheet analysis, traders can create a robust methodology for identifying Amer entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.